会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 8. 发明申请
    • ADDITIVE FOR ACCELERATING HYBRIDIZATION
    • 用于加速混合的添加剂
    • WO2016125091A1
    • 2016-08-11
    • PCT/IB2016/050548
    • 2016-02-03
    • ALMA MATER STUDIORUM UNIVERSITA DI BOLOGNA
    • DI OTO, EnricoMONTI, ValentinaASIOLI, Sofia
    • C12Q1/68
    • C12Q1/6832C12Q1/6841C12Q2527/125C12Q2527/153
    • The present invention describes an additive for accelerating hybridization comprising: a) an aqueous solution of sodium dextran sulphate, b) a salt, c) a buffer system, d) a strong mineral base possibly mixed with at least one polar aprotic solvent, or at least one polar aprotic solvent. The additive described herein enables a reduction in the time required to perform the investigations with molecular probes on histological and cytological samples; the possibility of applying it to the protocol already in use in the routine practices of various laboratories in order to reduce the working time of histological and cytological samples for investigations with molecular probes, with no organisational impacts on the operators' work, enabling a more rapid diagnostic response for the patient and offering the possibility of using the additive described herein without formamide.
    • 本发明描述了用于加速杂交的添加剂,其包括:a)硫酸葡聚糖钠水溶液,b)盐,c)缓冲体系,d)可能与至少一种极性非质子溶剂混合的强矿物碱,或 至少一种极性非质子溶剂。 本文所述的添加剂能够减少用分子探针对组织学和细胞学样品进行研究所需的时间; 将其应用于已经在各种实验室的常规实践中使用的方案,以减少组织学和细胞学样本的工作时间用于分子探针的研究,对运营人的工作没有任何组织影响,从而能够更快速地 对患者的诊断反应并且提供使用本文所述添加剂而不需要甲酰胺的可能性。
    • 9. 发明申请
    • GENOMIC CLASSIFIER THAT PREDICTS RESPONSE TO MULTI-KINASE INHIBITOR TREATMENT INTRODUCTION
    • 预测应用于多种激酶抑制剂治疗的基因组分类器简介
    • WO2016097285A1
    • 2016-06-23
    • PCT/EP2015/080475
    • 2015-12-18
    • CENTRE LÉON-BÉRARD
    • BLAY, Jean-YvesJIANG, XiaojunTREDAN, OlivierRAY COQUARD, Isabelle
    • C12Q1/68
    • C12Q1/6886C12Q1/6809C12Q1/6827C12Q1/6832C12Q1/6874C12Q2539/115C12Q2600/106C12Q2600/156
    • The method for predicting the anti-tumor response in a human or animal having a tumor to multiple kinase inhibitors, using any multiple kinase inhibitor, comprises selection of genes encoding for protein kinases targeted by the said tyrosine kinase inhibitor, for each one of these genes, providing at least one nucleic acid probe which hybridizes to said gene under stringent conditions, thus providing an array of nucleic acid probes, having a biological sample containing cancer cells from said human or animal, extracting DNA from the sample, fragmenting into DNA fragments, optionally labeling the DNA fragments, submitting the optionally labeled DNA fragments to hybridization with the array of nucleic acid probes, recovering and quantifying for all the genes the gains or losses in gene copy numbers, wherein gains and losses of gene copy numbers of each selected gene are used to determine whether the tumor is sensitive or not to said kinase inhibitor.
    • 使用任何多重激酶抑制剂预测具有多种激酶抑制剂的肿瘤的人或动物的抗肿瘤反应的方法包括选择编码由所述酪氨酸激酶抑制剂靶向的蛋白激酶的基因,对于这些基因中的每一个 提供至少一种在严格条件下与所述基因杂交的核酸探针,从而提供核酸探针阵列,其具有含有来自所述人或动物的癌细胞的生物样品,从样品中提取DNA,分段成DNA片段, 任选地标记DNA片段,将任选标记的DNA片段与核酸探针阵列杂交,回收和定量所有基因的基因拷贝数中的增益或损失,其中每个选择的基因的基因拷贝数的增益和损失 用于确定肿瘤是否对所述激酶抑制剂敏感。